Ethoxyresorufin O-deethylation by human liver microsomes.-Reference-Cited by-同舟云学术

Ethoxyresorufin O-deethylation by human liver microsomes.

Published:1986-09 Issue:3 Volume:22 Page:263-268
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Williams FM,Mutch E,Woodhouse KW,Lambert D,Rawlins MD

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1986.tb02885.x/fullpdf

Reference10 articles.

1. Genetic association of increases in naphthalene, acetanilide and biphenyl hydroxylations with inducible aryl hydrocarbon hydroxylase in mice;Atlas;Arch. Biochem. Biophys.,1976

2. Comparative metabolism of debrisoquine 7-ethoxyresomfin and benz(alpha) pyrene in liver microsomes from humans and from rats treated with cytochrome P450 inducers;Birgesson;Acta Pharmac Tox.,1985

3. Ethoxyresorufin in direct fluorometric assay of a microsomal O-de-ethylation which is preferentially inducible by 3-methylcholanthrene;Burke;Drug Metab. Dispos.,1974

4. Differential effects of phenobarbitone and 3-methylcholanthrene induction of the hepatic microsomal metabolism and cytochrome P450 binding of phenoxazone and a homologous series of its n alkyl ethers (alkoxy resorufins);Burke;Chem. Biol. Interact.,1983

5. A non-linear regression program for small computers;Duggelby;Analyt. Biochem.,1981

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lack of inhibitory effect of wood creosote on cytochrome P450‐mediated drug metabolism;Traditional & Kampo Medicine;2021-11-15

2. Effect of Benifuuki Tea on Cytochrome P450-mediated Metabolic Activity in Rats;In Vivo;2018-01-02

3. Inhibition of human and rat CYP1A1 enzyme by grapefruit juice compounds;Toxicology Letters;2016-09

4. Inhibitory Effect of Antituberculosis Drugs on Human Cytochrome P450-Mediated Activities;Journal of Pharmacological Sciences;2004

5. Involvement of CYP1A2 in mexiletine metabolism;British Journal of Clinical Pharmacology;1998-07